Exenatide (exendin-4) clinical trials: 194 trials
Page 1 of 4
Read 194 Exenatide (exendin-4) clinical trials with posted results or linked papers with results in PepBank.
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
NCT01144338 · Phase 3 · Completed
Posted results
- A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
NCT00960661 · Phase 3 · Completed
Posted results
- Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
NCT00359762 · Phase 3 · Completed
Posted results
- A Study in Participants With Type 2 Diabetes Mellitus
NCT01064687 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
NCT01029886 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
NCT00676338 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
NCT01885208 · Phase 3 · Completed
Posted results
- Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
NCT02229396 · Phase 3 · Completed
Posted results
- A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
NCT00917267 · Phase 3 · Completed
Posted results
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
NCT00707031 · Phase 3 · Completed
Posted results
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
NCT00082381 · Phase 3 · Completed
Posted results
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
NCT02787551 · Phase 3 · Completed
Posted results
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
NCT00637273 · Phase 3 · Completed
Posted results
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
NCT00082407 · Phase 3 · Completed
Posted results
- Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
NCT00434954 · Phase 3 · Completed
Posted results
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00518882 · Phase 3 · Completed
Posted results
- Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
NCT00641056 · Phase 3 · Completed
Posted results
- Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
NCT02229383 · Phase 3 · Completed
Posted results
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
NCT01676116 · Phase 3 · Completed
Posted results
- Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
NCT00935532 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
NCT01652716 · Phase 3 · Completed
Posted results
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
NCT01652729 · Phase 3 · Completed
Posted results
- Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
NCT01107717 · Phase 4 · Completed
Posted results
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
NCT00308139 · Phase 3 · Completed
Posted results
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
NCT00765817 · Phase 3 · Completed
Posted results
- A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
NCT00870194 · Phase 4 · Completed
Posted results
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
NCT00877890 · Phase 3 · Completed
Posted results
- Weight Loss With Exenatide Treatment
NCT01590433 · Phase 4 · Completed
Posted results
- Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
NCT02288273 · Phase 4 · Completed
Posted results
- A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
NCT00360334 · Phase 3 · Completed
Posted results
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
NCT01003184 · Phase 3 · Completed
Posted results
- Effect on Weight Loss of Exenatide Versus Placebo
NCT00375492 · Phase 3 · Completed
Posted results
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
NCT02072096 · Phase 4 · Terminated
Posted results
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
NCT00577824 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
NCT00603239 · Phase 3 · Completed
Posted results
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
NCT02455076 · Phase 4 · Completed
Posted results
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
NCT00856609 · Phase 3 · Completed
Posted results
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
NCT00135330 · Phase 3 · Completed
Posted results
- Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
NCT00753896 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
NCT00658021 · Phase 3 · Completed
Posted results
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
NCT02635386 · Phase 3 · Completed
Posted results
- A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.
NCT02533453 · Phase 4 · Completed
Posted results
- Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
NCT03331289 · Phase 4 · Completed
Posted results
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
NCT01524705 · Phase 4 · Completed
Posted results
- Liver and Fat Regulation in Overweight Adolescent Girls
NCT02157974 · Phase 2/3 · Completed
Posted results
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
NCT02981069 · Phase 4 · Completed
Posted results
- Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
NCT01554618 · Phase 3 · Completed
Posted results
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
NCT00729326 · Phase 4 · Completed
Posted results
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
NCT01181986 · Phase 4 · Completed
Posted results
- The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
NCT00353834 · Phase 4 · Completed
Posted results